FY27 may be a bit difficult for pharma companies due to UD effect; betting on 2 stocks ...
Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...
Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy's slump 2-4%
Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...
pharmaphorum23 小时
How pharmaceutical companies can speed up construction projects
Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...
MM&M4 天
Pharma brands are struggling to keep the attention of digitally savvy HCPs
May I have your attention, please? May I have your attention, please? Aside from being an Eminem lyric, it’s also a sincere request from pharma brands to healthcare professionals (HCPs). HCP marketing ...
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Over 3k brands hit pharma mkt, cancer drug tops in sales
India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the ...
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and ...
Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...
MM&M1 天
How new direct-to-consumer platforms are changing pharma’s relationships with patients
New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.